Found 10 matching trials
LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure PHASE2 This study evaluates a personalized treatment strategy for patients with la...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Learn More & Join Trial
A Study to Evaluate Zanubrutinib and Tislelizumab in Progressive Lymphoma Post CAR-T PHASE2 This is a phase ll study of participants with large B Cell lymphoma previou...
Show More Location
University Health Network (UHN)
Learn More & Join Trial
Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes PHASE2 This is a prospective, open-label, single-arm, single-center, Phase II clin...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
Zanubrutinib Combined With Tislelizumab in the Treatment of r/r PMBCL and EBV+ DLBCL PHASE2 The study is to investigate the safety and efficacy of Zanubrutinib combine...
Show More Learn More & Join Trial
Immunobridging/Maintenance Therapy Versus Non-bridging Therapy in CAR-T Therapy for Low-risk R/R B-NHL PHASE2 This study aims to explore whether adding immunotherapy bridging treatment ...
Show More Learn More & Join Trial
Study of BGB-10188 as Monotherapy, and in Combination With Zanubrutinib, and Tislelizumab PHASE1 The purpose of this study was to determine the maximum tolerated dose (MTD)...
Show More Location
Blacktown Cancer and Haematology Centre
Learn More & Join Trial
A Study to Evaluate Long-term Safety of Zanubrutinib Regimens in Participants With B-Cell Malignancies Who Participated in BeiGene Parent Studies of Zanubrutinib PHASE3 The purpose of this study is to learn about the long-term safety and effect...
Show More Status
Active Not Recruiting
Location
Banner Md Anderson Cancer Center
Learn More & Join Trial
Zanubrutinib (BGB-3111) in Combination With Tislelizumab (BGB-A317) in Participants With B-cell Malignancies PHASE1 This study is evaluating the safety and preliminary efficacy of BGB-3111 in...
Show More Location
St Vincent's Hospital
Learn More & Join Trial
Efficacy and Safety of Zanubrutinib, Rituximab, and Lenalidomide (ZR²) in Combination With Tislelizumab for Relapsed/Refractory Follicular Lymphoma PHASE2 This is a prospective, open-label, single-arm, single-center, Phase II clin...
Show More Location
Jiangsu Province Hospital
Learn More & Join Trial
Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment With or Without Sonrotoclax for Patients With Richter Transformation PHASE2 The aim of the CLL-RT1 trial is to evaluate the efficacy and safety of zanu...
Show More Location
Allgemeines Krankenhaus der Stadt Wien
Learn More & Join Trial